EC
TMO icon

EntryPoint Capital’s Thermo Fisher Scientific TMO Stock Holding History

EntryPoint Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16
Closed -$9.3K – 1610
2024
Q1 		$9.3K Buy
+16
New +$8.98K 0.01% 1246

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EntryPoint Capital's TMO Position: Q2 2024 in Review

EntryPoint Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 16 shares — an estimated $9.3K sold.

EntryPoint Capital first reported a position in TMO in Q1 2024 and held it in 1 quarter. The position peaked at $9.3K in Q1 2024. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • EntryPoint Capital reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • EntryPoint Capital sold 16 Thermo Fisher Scientific shares in Q2 2024, an estimated $9.3K.
  • EntryPoint Capital first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 1 quarter.
  • EntryPoint Capital's Thermo Fisher Scientific position peaked at $9.3K in Q1 2024.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.